Zentalis Pharmaceuticals (ZNTL) EPS (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) EPS from Jun 30, 2020 to Mar 31, 2026. The TTM Zentalis Pharmaceuticals (ZNTL) EPS is -$1.75. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Zentalis Pharmaceuticals (ZNTL) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -44.37% |
| 3 Years TTM | -25.00% |
| 5 Years TTM | -14.37% |
| All Time TTM | -17.54% |
Annual EPS change of Zentalis Pharmaceuticals (ZNTL)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.50 | -74.96% |
| 2025 | -$1.98 | -14.73% |
| 2024 | -$2.33 | -43.65% |
| 2023 | -$4.13 | +3.36% |
| 2022 | -$3.99 | +14.49% |
| 2021 | -$3.49 | +21.51% |
| 2020 | -$2.87 | N/A |
Comparison Zentalis Pharmaceuticals (ZNTL) five years EPS CAGR with competitors
Zentalis Pharmaceuticals (ZNTL) five years EPS CAGR is -14.37%.